Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Cachexia × RC-1291 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cancer Cachexia 1

Interventions

kang-lai-te 2 ruxolitinib 1 macimorelin 1 RC-1291 1 Pharmacogenomic Testing 1 Omacor 1 Isophane Insulin, Human 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Capsules 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00378131 2013-09-02

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia

Helsinn Therapeutics (U.S.), Inc

Phase 2 Completed

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡